EP1446492A2 - Process for the preparation of an enantiomerically enriched a-amino acid - Google Patents
Process for the preparation of an enantiomerically enriched a-amino acidInfo
- Publication number
- EP1446492A2 EP1446492A2 EP02783830A EP02783830A EP1446492A2 EP 1446492 A2 EP1446492 A2 EP 1446492A2 EP 02783830 A EP02783830 A EP 02783830A EP 02783830 A EP02783830 A EP 02783830A EP 1446492 A2 EP1446492 A2 EP 1446492A2
- Authority
- EP
- European Patent Office
- Prior art keywords
- amino acid
- carbamoyl
- process according
- hydantoinase
- conversion
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000002360 preparation method Methods 0.000 title claims abstract description 20
- 238000006243 chemical reaction Methods 0.000 claims abstract description 47
- 150000007650 D alpha amino acids Chemical class 0.000 claims abstract description 36
- 102000004190 Enzymes Human genes 0.000 claims abstract description 23
- 108090000790 Enzymes Proteins 0.000 claims abstract description 23
- 108091022884 dihydropyrimidinase Proteins 0.000 claims abstract description 23
- 102100036238 Dihydropyrimidinase Human genes 0.000 claims abstract description 22
- 150000007649 L alpha amino acids Chemical class 0.000 claims abstract description 14
- 108010000622 N-carbamoyl-D-amino acid amidohydrolase Proteins 0.000 claims abstract description 14
- 241000157908 Paenarthrobacter aurescens Species 0.000 claims abstract description 14
- 241000589155 Agrobacterium tumefaciens Species 0.000 claims abstract description 12
- 235000008206 alpha-amino acids Nutrition 0.000 claims abstract description 10
- 238000005580 one pot reaction Methods 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims description 18
- 108010088443 hydantoin racemase Proteins 0.000 claims description 9
- 101710090249 D-hydantoinase Proteins 0.000 claims description 8
- ROHFNLRQFUQHCH-RXMQYKEDSA-N D-leucine Chemical compound CC(C)C[C@@H](N)C(O)=O ROHFNLRQFUQHCH-RXMQYKEDSA-N 0.000 claims description 5
- 229930182819 D-leucine Natural products 0.000 claims description 5
- 150000001370 alpha-amino acid derivatives Chemical class 0.000 claims description 5
- COLNVLDHVKWLRT-MRVPVSSYSA-N D-phenylalanine Chemical compound OC(=O)[C@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-MRVPVSSYSA-N 0.000 claims description 4
- 229930182832 D-phenylalanine Natural products 0.000 claims description 4
- 101710192191 L-hydantoinase Proteins 0.000 claims description 4
- HBAQYPYDRFILMT-UHFFFAOYSA-N 8-[3-(1-cyclopropylpyrazol-4-yl)-1H-pyrazolo[4,3-d]pyrimidin-5-yl]-3-methyl-3,8-diazabicyclo[3.2.1]octan-2-one Chemical class C1(CC1)N1N=CC(=C1)C1=NNC2=C1N=C(N=C2)N1C2C(N(CC1CC2)C)=O HBAQYPYDRFILMT-UHFFFAOYSA-N 0.000 claims description 3
- FFEARJCKVFRZRR-SCSAIBSYSA-N D-methionine Chemical compound CSCC[C@@H](N)C(O)=O FFEARJCKVFRZRR-SCSAIBSYSA-N 0.000 claims description 3
- XUJNEKJLAYXESH-UWTATZPHSA-N D-Cysteine Chemical compound SC[C@@H](N)C(O)=O XUJNEKJLAYXESH-UWTATZPHSA-N 0.000 claims 1
- 229930182818 D-methionine Natural products 0.000 claims 1
- AYFVYJQAPQTCCC-STHAYSLISA-N D-threonine Chemical compound C[C@H](O)[C@@H](N)C(O)=O AYFVYJQAPQTCCC-STHAYSLISA-N 0.000 claims 1
- 229930182822 D-threonine Natural products 0.000 claims 1
- 229930195710 D‐cysteine Natural products 0.000 claims 1
- -1 N-carbamoyl-amino Chemical group 0.000 claims 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract description 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract description 5
- 150000001371 alpha-amino acids Chemical class 0.000 abstract description 5
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract description 5
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract description 4
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract description 4
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract description 4
- 239000004473 Threonine Substances 0.000 abstract description 4
- 235000018417 cysteine Nutrition 0.000 abstract description 4
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract description 4
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract description 3
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract description 3
- 229930182817 methionine Natural products 0.000 abstract description 3
- 229940088598 enzyme Drugs 0.000 description 21
- 229940091173 hydantoin Drugs 0.000 description 17
- 150000001469 hydantoins Chemical class 0.000 description 17
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 15
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 11
- 239000011541 reaction mixture Substances 0.000 description 10
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 9
- 230000000694 effects Effects 0.000 description 9
- 239000000243 solution Substances 0.000 description 9
- 238000004128 high performance liquid chromatography Methods 0.000 description 8
- 239000013612 plasmid Substances 0.000 description 6
- 108020004414 DNA Proteins 0.000 description 5
- 229940024606 amino acid Drugs 0.000 description 5
- 239000000284 extract Substances 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 239000012299 nitrogen atmosphere Substances 0.000 description 5
- 229960005190 phenylalanine Drugs 0.000 description 5
- JUIBQJHHPDRAGP-YFKPBYRVSA-N (2s)-2-(carbamoylamino)-4-methylpentanoic acid Chemical compound CC(C)C[C@@H](C(O)=O)NC(N)=O JUIBQJHHPDRAGP-YFKPBYRVSA-N 0.000 description 4
- 238000003556 assay Methods 0.000 description 4
- 239000006285 cell suspension Substances 0.000 description 4
- 150000001875 compounds Chemical class 0.000 description 4
- 238000006911 enzymatic reaction Methods 0.000 description 4
- WJRBRSLFGCUECM-UHFFFAOYSA-N hydantoin Chemical compound O=C1CNC(=O)N1 WJRBRSLFGCUECM-UHFFFAOYSA-N 0.000 description 4
- 235000008729 phenylalanine Nutrition 0.000 description 4
- 230000035484 reaction time Effects 0.000 description 4
- 241000588724 Escherichia coli Species 0.000 description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 3
- 108700026244 Open Reading Frames Proteins 0.000 description 3
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 3
- 235000001014 amino acid Nutrition 0.000 description 3
- 150000001413 amino acids Chemical class 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 238000010367 cloning Methods 0.000 description 3
- 229960002433 cysteine Drugs 0.000 description 3
- IPWQOZCSQLTKOI-QMMMGPOBSA-N d-[(amino)carbonyl]phenylalanine Chemical compound NC(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 IPWQOZCSQLTKOI-QMMMGPOBSA-N 0.000 description 3
- 239000003480 eluent Substances 0.000 description 3
- 229960003136 leucine Drugs 0.000 description 3
- 229960002898 threonine Drugs 0.000 description 3
- 235000008521 threonine Nutrition 0.000 description 3
- 238000004448 titration Methods 0.000 description 3
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 2
- JDNXAWFLEXAACH-GBXIJSLDSA-N (2s,3r)-2-(carbamoylamino)-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(N)=O JDNXAWFLEXAACH-GBXIJSLDSA-N 0.000 description 2
- DEWDMTSMCKXBNP-UHFFFAOYSA-N 2-(carbamoylamino)-4-methylsulfanylbutanoic acid Chemical compound CSCCC(C(O)=O)NC(N)=O DEWDMTSMCKXBNP-UHFFFAOYSA-N 0.000 description 2
- 241000589159 Agrobacterium sp. Species 0.000 description 2
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 2
- 150000008574 D-amino acids Chemical class 0.000 description 2
- 241000588697 Enterobacter cloacae Species 0.000 description 2
- 108091092584 GDNA Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 2
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 2
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 2
- 239000004472 Lysine Substances 0.000 description 2
- 241001468261 Lysinibacillus macroides Species 0.000 description 2
- 102000016943 Muramidase Human genes 0.000 description 2
- 108010014251 Muramidase Proteins 0.000 description 2
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 2
- APFSAMXTZRYBKF-REOHCLBHSA-N N-carbamoyl-L-cysteine Chemical compound NC(=O)N[C@@H](CS)C(O)=O APFSAMXTZRYBKF-REOHCLBHSA-N 0.000 description 2
- 241000589774 Pseudomonas sp. Species 0.000 description 2
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 2
- 235000009582 asparagine Nutrition 0.000 description 2
- 229960001230 asparagine Drugs 0.000 description 2
- FPPNZSSZRUTDAP-UWFZAAFLSA-N carbenicillin Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)C(C(O)=O)C1=CC=CC=C1 FPPNZSSZRUTDAP-UWFZAAFLSA-N 0.000 description 2
- 229960003669 carbenicillin Drugs 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 235000004554 glutamine Nutrition 0.000 description 2
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 235000005772 leucine Nutrition 0.000 description 2
- 235000018977 lysine Nutrition 0.000 description 2
- 229960000274 lysozyme Drugs 0.000 description 2
- 239000004325 lysozyme Substances 0.000 description 2
- 235000010335 lysozyme Nutrition 0.000 description 2
- 229960004452 methionine Drugs 0.000 description 2
- 235000006109 methionine Nutrition 0.000 description 2
- 244000005700 microbiome Species 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 230000006340 racemization Effects 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 235000004400 serine Nutrition 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 1
- 241000187844 Actinoplanes Species 0.000 description 1
- 241000607534 Aeromonas Species 0.000 description 1
- 241000589158 Agrobacterium Species 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 108010023063 Bacto-peptone Proteins 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 238000007399 DNA isolation Methods 0.000 description 1
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 108010067770 Endopeptidase K Proteins 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 241000589565 Flavobacterium Species 0.000 description 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 description 1
- RHGKLRLOHDJJDR-BYPYZUCNSA-N L-citrulline Chemical compound NC(=O)NCCC[C@H]([NH3+])C([O-])=O RHGKLRLOHDJJDR-BYPYZUCNSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- 239000004395 L-leucine Substances 0.000 description 1
- 235000019454 L-leucine Nutrition 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 241000192041 Micrococcus Species 0.000 description 1
- DEWDMTSMCKXBNP-BYPYZUCNSA-N N-carbamoyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC(N)=O DEWDMTSMCKXBNP-BYPYZUCNSA-N 0.000 description 1
- RHGKLRLOHDJJDR-UHFFFAOYSA-N Ndelta-carbamoyl-DL-ornithine Natural products OC(=O)C(N)CCCNC(N)=O RHGKLRLOHDJJDR-UHFFFAOYSA-N 0.000 description 1
- 241000187654 Nocardia Species 0.000 description 1
- 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
- 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
- 241001057811 Paracoccus <mealybug> Species 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000589516 Pseudomonas Species 0.000 description 1
- 241000607720 Serratia Species 0.000 description 1
- 108091081024 Start codon Proteins 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 235000009697 arginine Nutrition 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 235000003704 aspartic acid Nutrition 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 239000013611 chromosomal DNA Substances 0.000 description 1
- 235000013477 citrulline Nutrition 0.000 description 1
- 229960002173 citrulline Drugs 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000000287 crude extract Substances 0.000 description 1
- 230000009089 cytolysis Effects 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000012239 gene modification Methods 0.000 description 1
- 230000005017 genetic modification Effects 0.000 description 1
- 235000013617 genetically modified food Nutrition 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 235000013922 glutamic acid Nutrition 0.000 description 1
- 239000004220 glutamic acid Substances 0.000 description 1
- 125000005842 heteroatom Chemical group 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 235000014304 histidine Nutrition 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 229960000310 isoleucine Drugs 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 235000014705 isoleucine Nutrition 0.000 description 1
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
- 239000006166 lysate Substances 0.000 description 1
- VWHRYODZTDMVSS-QMMMGPOBSA-N m-fluoro-L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC(F)=C1 VWHRYODZTDMVSS-QMMMGPOBSA-N 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000002703 mutagenesis Methods 0.000 description 1
- 231100000350 mutagenesis Toxicity 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 239000002773 nucleotide Substances 0.000 description 1
- 125000003729 nucleotide group Chemical group 0.000 description 1
- 229940046166 oligodeoxynucleotide Drugs 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000000813 peptide hormone Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- GKKCIDNWFBPDBW-UHFFFAOYSA-M potassium cyanate Chemical compound [K]OC#N GKKCIDNWFBPDBW-UHFFFAOYSA-M 0.000 description 1
- 230000006920 protein precipitation Effects 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 238000002708 random mutagenesis Methods 0.000 description 1
- 108091008146 restriction endonucleases Proteins 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 125000000547 substituted alkyl group Chemical group 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000009466 transformation Effects 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 235000002374 tyrosine Nutrition 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 239000004474 valine Substances 0.000 description 1
- 235000014393 valine Nutrition 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/08—Lysine; Diaminopimelic acid; Threonine; Valine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/06—Alanine; Leucine; Isoleucine; Serine; Homoserine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/12—Methionine; Cysteine; Cystine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P13/00—Preparation of nitrogen-containing organic compounds
- C12P13/04—Alpha- or beta- amino acids
- C12P13/22—Tryptophan; Tyrosine; Phenylalanine; 3,4-Dihydroxyphenylalanine
- C12P13/222—Phenylalanine
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
- C12P41/00—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture
- C12P41/006—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures
- C12P41/009—Processes using enzymes or microorganisms to separate optical isomers from a racemic mixture by reactions involving C-N bonds, e.g. nitriles, amides, hydantoins, carbamates, lactames, transamination reactions, or keto group formation from racemic mixtures by reactions involving hydantoins or carbamoylamino compounds
Definitions
- the invention relates to a process for the preparation of an enantiomerically enriched D- ⁇ -amino acid in a one pot reaction in the presence of a hydantoinase and a D-carbamoylase.
- D- ⁇ -amino acids can be prepared enzymatically from a mixture of the corresponding D- and L-5-substituted hydantoin. Such a process is known from EP 0 775 748.
- a mixture of D- and L-5-substituted hydantoin is enantioselectively converted into the corresponding D- ⁇ -amino acid in a one pot reaction in the presence of a D-hydantoinase and a D-carbamoylase.
- Enantiomerically enriched ⁇ -amino acids are important building blocks for biologically active preparations such as, for example, ⁇ -lactam antibiotics, peptide hormones and pesticides.
- a drawback of this process is that the starting material for the preparation of the enantiomerically enriched ⁇ -amino acid, the corresponding 5- substituted hydantoin, is usually difficult to handle due to the poor water solubility of most 5-substituted hydantoins.
- the invention aims to provide a simple process for the preparation of a D- ⁇ -amino acid in which use can be made of a starting material that it easier to handle than a 5-substituted hydantoin. According to the invention this is achieved through conversion of an N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ - amino acid.
- N-carbamoyl-L- ⁇ -amino acids can easily be prepared from the corresponding L- ⁇ -amino acids the invention also provides a process by means of which D- ⁇ -amino acids can be prepared rapidly and in a high yield from the corresponding L- ⁇ -amino acids.
- L- ⁇ -amino acids are usually cheap and widely available.
- the process according to the invention is eminently suited for preparing D- ⁇ -amino acids from L- ⁇ -amino acids which, when they are chemically converted into the corresponding hydantoins, yield less stable hydantoins (as a result of which a great deal of by-product formation takes place on chemical conversion of these L- ⁇ -amino acids into the corresponding hydantoins).
- ⁇ -amino acids are serine, asparagine, glutamine, lysine, threonine and cysteine.
- carbamoylase is known from the literature.
- the expert understands carbamoylase to be an enzyme with carbamoylase activity, that is, the ability to catalyze the conversion of N-carbamoyl- ⁇ -amino acid into the corresponding ⁇ -amino acid.
- the expert understands D-carbamoylase to be an enzyme that preferably catalyzes the conversion of N-carbamoyl-D- ⁇ -amino acid into the corresponding D- ⁇ -amino acid.
- the D-carbamoylase involved in the process for the preparation of a D- ⁇ -amino acid according to the invention preferably has a selectivity of at least 90%, more in particular at least 95%, even more in particular at least 98% and most particularly at least 99%.
- a 90% selectivity of the D-carbamoylase is understood to mean that the D-carbamoylase converts the N- carbamoyl-(D,L)- ⁇ -amino acid into 90% D- ⁇ -amino acid and 10% L- ⁇ -amino acid at an overall conversion of 50%, which corresponds to an enantiomeric excess (e.e.) of 80% of the D- ⁇ -amino acid at 50% conversion.
- hydantoinase is known from the literature. The expert understands hydantoinase to be an enzyme with hydantoinase activity, that is, the ability to catalyze the reaction of 5-substituted hydantoin to form the corresponding N- carbamoyl- ⁇ -amino acid.
- the hydantoinase activity that is required for the process according to the invention may be provided by one or by more hydantoinases.
- the enantioselectivity of the hydantoinase(s) involved in the conversion of N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid is not very critical.
- a D-hydantoinase for example, a D-hydantoinase, an L-hydantoinase or a non enantioselective hydantoinase may be employed as well as combinations thereof.
- the expert understands a D-hydantoinase to be a hydantoinase that preferably catalyzes the reversible hydrolysis of a 5- substituted D-hydantoin into the corresponding N-carbamoyl-D- ⁇ -amino acid.
- D-hydantoinase can be employed in the process of the invention as it is generally assumed that D-hydantoinases are strictly D-selective (Drauz, K., Waldmann, H, Enzyme catalysis in organic synthesis - a comprehensive handbook, second, completely revised and enlarged edition, volume III, Wiley-VCH Verlag GmbH, Weinheim 2002) and therefore the person skilled in the art would not expect that N- carbamoyl-L- ⁇ -amino acid can be converted by a D-hydantoinase.
- the conversion of N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid according to the invention is carried out in the presence of a hydantoin racemase.
- Hydantoin racemases are known from the literature (for example from WO 01/23582 A1). The expert understands a hydantoin racemase to be an enzyme with hydantoin racemase activity, that is, the ability to catalyze the racemization of the L-5-substituted hydantoin (or D-5 substituted hydantoin).
- N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid according to the invention is carried out at a pH between 5 and 10. In particular, the conversion is carried out at a pH between 6.0 and 7.5.
- the temperature of the conversion of N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid is preferably chosen between 0 and 80°C, in particular between 10 and 50°C, more in particular between 35 and 45°C.
- the reaction conditions in the process according to the invention are chosen such that the formed enantiomerically enriched D- ⁇ -amino acid crystallizes out, facilitating the recovery of the enantiomerically enriched D- ⁇ -amino acid.
- the process for converting N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid is used in the preparation of a D- ⁇ -amino acid from the corresponding L- ⁇ -amino acid.
- Use is made of the same process as described above, to which an extra step is added, namely the preparation of N-carbamoyl-L- ⁇ - amino acid from the corresponding L- ⁇ -amino acid.
- N-carbamoyl- ⁇ - amino acid from the corresponding ⁇ -amino acid can for example be effected chemically by contacting the ⁇ -amino acid with, for example, MOCN, where M represents alkali metal, preferably potassium or sodium in the presence of water.
- MOCN alkali metal
- the temperature used is not critical: the reaction preferably takes place at temperatures between about -5 and 100°C, preferably at temperatures between 0 and 80 C C; the pH of the chemical reaction is preferably chosen between 8 and 11 , more in particular between 9 and 10.
- the preparation of D- ⁇ -amino acid from the corresponding L- ⁇ -amino acid via the corresponding N-carbamoyl-L- ⁇ -amino acid is carried out in a single vessel.
- This has the advantage that no intermediate recovery of the N- carbamoyl- ⁇ -amino acid is needed.
- the invention is in no way limited by the form in which the enzymes are used for the present invention.
- the different enzymes may each independently be present in a certain form.
- the enzymes may for example be present as a crude enzyme solution or as purified enzyme.
- the enzymes may for example also be present in (permeabilized and/or immobilized) cells that naturally or through genetic modification possess the desired enzymes/enzyme activity, or in a lysate of cells with such activity.
- the enzymes can for example also be used in immobilized form or in chemically modified form. It will be clear to the average person skilled in the art that use can also be made of mutants of naturally occurring (wild type) enzymes with hydantoinase and/or enantioselective carbamoylase and/or hydantoin racemase activity in the process according to the invention.
- Mutants of wild-type enzymes can for example be made by modifying the DNA encoding the wild type enzymes using the mutagenesis techniques known to the person skilled in the art (random mutagenesis, site-directed mutagenesis, directed evolution, gene shuffling, etc.) so that the DNA encodes an enzyme that differs by at least one amino acid from the wild type enzyme and by effecting the expression of the thus modified DNA in a suitable (host) cell.
- Suitable hydantoinases and/or D-carbamoylases and/or hydantoin racemases for the process according to the present invention can be present in, or originate from, for example the microorganisms that usually also supply the enzymes for the hydantoinase-carbamoylase processes, for example the microorganisms of the following genera: Pseudomonas, preferably Pseudomonas sp., more in particular Pseudomonas sp.
- FERM BP 1900 Hansenula, Agrobacterium, preferably Agrobacterium sp. or Agrobacterium radiobacter. more in particular Agrobacterium sp.
- Aerobacter preferably Aerobacter cloacae, more in particular Aerobacter cloacae IAM 1221 , Aeromonas, Bacillus, preferably Bacillus macroides, more in particular Bacillus macroides ATCC 12905. Brevibacterium. Flavobacterium, Serratia, Micrococcus, Arthrobacter, preferably Arthrobacter aurescens. more in particular Arthrobacter aurescens DSM 3747 Nocardia, Corvnebacterium, Mvcobacterium. Actinoplanes, Streptomvces or Paracoccus.
- hydantoinases and/or D-carbamoylases and/or hydantoin racemases may vary dependent on the specific substrate/desired D- ⁇ -amino acid and can easily be determined by the person skilled in the art.
- one or more of the enzymes used in the conversion of N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid according to the invention originate from Agrobacterium radiobacter or Arthrobacter aurescens.
- the invention can be used in the preparation of both proteinogenic and non-proteinogenic D-enantiomers of ⁇ -amino acids having the formula R-CH(NH 2 )- COOH, where R represents an amino acid restgroup, for example a substituted or non- substituted alkyl group with for example 1-20 C atoms or a substituted or a non- substituted (hetero)aryl group with for example 1-20 C atoms.
- Examples of ⁇ -amino acids having the formula R-CH(NH 2 )-COOH are: alanine, valine, leucine, isoleucine, serine, threonine, methionine, cysteine, asparagine, glutamine, tyrosine, tryptophan, aspartic acid, glutamic acid, histidine, lysine, arginine, citrulline, phenylalanine, 3- fluorophenylalanine.
- the invention is used in the preparation of the D- enantiomers of methionine, leucine, cysteine, threonine or phenylalanine.
- Figure 1 shows the conversion of L- ⁇ -amino acid to D- ⁇ -amino acid; the compounds 1, 2 and 3 represent compounds with the L-configuration and the compounds 4, 5, and 6 compounds with the D-configuration.
- R represents an amino acid restgroup as defined above.
- N-carbamoyl-L- ⁇ -amino acid The conversion of N-carbamoyl-L- ⁇ -amino acid from the corresponding L- ⁇ -amino acid is shown in the reaction from 1 to 2.
- a possible route for the conversion of N-carbamoyl-L- ⁇ -amino acid into the corresponding D- ⁇ -amino acid is shown in the reactions from 2 to 6.
- the N-carbamoyl-L- ⁇ -amino acid (2) is converted into the corresponding L-5-substituted hydantoin (3) in the presence of a hydantoinase and a D-carbamoylase.
- the L-5-substituted hydantoin is then racemized in situ.
- Racemization of L-5-substituted hydantoin may occur spontaneously, but can also be effected for example by means of heating or by using a hydantoin racemase.
- D-5 substituted hydantoin present in the mixture of enantiomers of 5-substituted hydantoin (4) formed is subsequently converted into the corresponding N-carbamoyl-D- ⁇ -amino acid (5), after which the N-carbamoyl-D- ⁇ -amino acid is converted to form the corresponding D- ⁇ -amino acid (6), use being made of the presence of a hydantoinase and a D-carbamoylase.
- N-carbamoyl-L-leucine was added to 100 ml water, after which the pH was adjusted to 7.2 by means of 10 N NaOH. The volume was then made up to 150 ml with water. This mixture was heated to 40°C. Subsequently, under a nitrogen atmosphere, the enzymatic reaction was started by the addition of 18 g of an Agrobacterium radiobacter cell suspension. The pH of the reaction mixture was kept constant at pH 7.2 by means of titration with 3 mol/l H 3 PO 4 . The composition of the reaction mixture was monitored by means of HPLC analysis.
- a slurry of 17.9 g (0.093 mol) N-carbamoyl-D,L-methionine in 115 ml water was transferred to a double-walled glass reactor.
- the mixture was heated to 40°C and its pH was adjusted to 7.2 by means of 10 N NaOH, after which the mixture was made up to a volume of 170 ml.
- 12 g of an Agrobacterium radiobacter cell suspension was added, after which the pH of the reaction mixture was kept constant at pH 7.2 by addition of 3 mol/l H 3 PO .
- the reaction was carried out under a nitrogen atmosphere.
- the composition of the reaction mixture was analyzed by means of HPLC analysis. After a reaction time of about 29 hours a conversion of > 88% on the basis of N-carbamoyl-D,L-methionine was reached. The enantiomeric excess of the formed D- methionine was > 96%.
- N-carbamoyl-L-leucine was added to 100 ml water, after which the pH was adjusted to 7.2 by means of 10 N NaOH. The volume was then made up to 170 ml with water. This mixture was heated to 40°C. Subsequently, under a nitrogen atmosphere, the enzymatic reaction was started by the addition of 14.2 g of an Agrobacterium radiobacter cell suspension. The pH of the reaction mixture was kept constant at pH 7.2 by means of titration with 3 mol/l H 3 PO 4 . The composition of the reaction mixture was monitored by means of HPLC analysis. After a reaction time of 44 hours the reaction was stopped.
- the composition of the reaction mixture was analyzed by means of HPLC analysis. After a reaction time of 42 hours a D-leucine concentration of 67 g/l was measured, which corresponds to a conversion of > 95% on the basis of the N- carbamoyl-L-leucine. The enantiomeric excess of the formed D-leucine was > 98%.
- N-carbamoyl-L-amino acid in case of N- carbamoyl-L-cysteine 18.4 g (80 mmol) and in case of N-carbamoyl-L-threonine 17.8g (110 mmol) was added.
- the pH of the mixture was brought to 7.2 using 5 mol/L NaOH, after which the volume was adjusted to 150 mL.
- the mixture was transferred to a thermostated reaction vessel and the temperature was adjusted to 40°C.
- the enzymatic reaction was started by adding 22 g of an Agrobacterium radiobacter celsuspension.
- Example VI A. Construction of plasmid pET101/D-TOPOhyuH
- A. aurescens DSM 3747 was cultivated at 28°C in K2 medium (4 g bacto peptone, 4 g yeast extract, 7.5 g glycin, 2 g KH 2 PO , 3.62 g K 2 HPO 4 , in H 2 O to 1 liter and adjusted to pH 7.0). 10 ml from a preculture was added to 75 ml K2 medium and incubated at 28°C. After 3 hours of incubation, 75 ⁇ l lysozyme (100 mg/ml) and 1.5 ml carbenicillin (50 mg/ml) were added and incubation was continued for another hour at 28°C.
- K2 medium 4 g bacto peptone, 4 g yeast extract, 7.5 g glycin, 2 g KH 2 PO , 3.62 g K 2 HPO 4 , in H 2 O to 1 liter and adjusted to pH 7.0. 10 ml from a preculture was added to 75 ml K2 medium and in
- the cells were isolated by centrifugation and resuspended in 2.5 ml solution consisting of 125 ⁇ l 1 M Tris-HCI, pH 8, 250 ⁇ l 0.5 M EDTA pH 8 and 2.125 ml Milli-Q. Then, 50 ⁇ l lysozyme (100 mg/ml) and 20 ⁇ l proteinase K (20 mg/ml) were added. This suspension was incubated at 37°C for 30 minutes. After adding 3 ml of Nuclei Lysis Solution of Promega (Leiden, The Netherlands), the solution was incubated again for 15 minutes at 80°C.
- a 1377 bp fragment comprising the open reading frame (ORF) for hydantoinase HyuH was amplified by PCR from the chromosomal DNA from Arthrobacter aurescens DSM 3747 (nucleotides 4651-6027 of accession number AF146701) using the following primers: ⁇ yuH-forward:
- the start-codon was changed from GTG into ATG for better expression in E. coli.
- the Platinum Pfx DNA Polymerase of Invitrogen was used to amplify the ORF.
- the 5 pET101/D-TOPOHyuH plasmids were transformed to E. coli BL21 STAR (DE3) One Shot cells (Invitrogen).
- the transformants were cultivated at 28°C in LB medium containing 100 mg/l carbenicillin and induced with 0.5 mM IPTG (final concentration) according to Invitrogen's protocol. After overnight incubation, the cells were harvested by centrifugation and washed with 0.2 M Tris-HCI pH 7.
- the assay mixture of 10 ml contained 0.1 M Tris-HCI buffer pH 8.5 with a) 4 mM phenylalanine hydantoin, or b) 1.8 mM tryptophan hydantoin.
- the assay was performed at 37°C and started by the addition of 0.75 ml cell free extract. Several samples of 0.5 ml were taken in time and the reaction was stopped by adding 5 ⁇ l 85% phosphoric acid to these samples. Next they were analyzed by HPLC and UV detection at a wavelength of 220 nm.
- a Nucleosil-120-5 C18 column (50x4 mm, 5 ⁇ from Macherey-Nagel, D ⁇ ren, Germany) was used. The column was eluted with eluent A (50mM H 3 PO 4 pH 2.7) and eluent B (50 v/v% eluent A and 50 v/v% acetonitril).
- ⁇ /-carbamoyl-phenylalanine or ⁇ /-carbamoyl-tryptophan was produced within 1 hour with cell free extracts derived from all 5 clones of £ co/ pET101 /D-TOPOhyuH tested.
- a 45 mL solution containing 1.8 g (8.6 mmol) N-carbamoyl-L- phenylalanine was brought to pH 7.2 using 5 mol/L NaOH.
- the reaction was thermostated at 40°C.
- the enzymatic reaction was started by adding 2 mL of an Agrobacterium radiobacter celsuspension and 2 mL of a cellfree extract from the £ co/ ET101/D-TOPOhyuH L-hydantoinase clone, which contained the L- hydantoinase from Arthrobacter aurescens DSM 3747.
- the pH of the reaction was kept at pH 7.2.
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Wood Science & Technology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Microbiology (AREA)
- General Chemical & Material Sciences (AREA)
- Biotechnology (AREA)
- Health & Medical Sciences (AREA)
- Biochemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Analytical Chemistry (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Enzymes And Modification Thereof (AREA)
Abstract
Description
Claims
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| NL1019416 | 2001-11-23 | ||
| NL1019416A NL1019416C2 (en) | 2001-11-23 | 2001-11-23 | Process for preparing an enantiomerically enriched α-amino acid. |
| PCT/NL2002/000758 WO2003044206A2 (en) | 2001-11-23 | 2002-11-22 | Process for the preparation of an enantiomerically enriched a-amino acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EP1446492A2 true EP1446492A2 (en) | 2004-08-18 |
Family
ID=19774336
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EP02783830A Withdrawn EP1446492A2 (en) | 2001-11-23 | 2002-11-22 | Process for the preparation of an enantiomerically enriched a-amino acid |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP1446492A2 (en) |
| JP (1) | JP2005509439A (en) |
| CN (1) | CN1592789A (en) |
| AU (1) | AU2002347652A1 (en) |
| NL (1) | NL1019416C2 (en) |
| WO (1) | WO2003044206A2 (en) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1928103B (en) * | 2006-08-30 | 2010-09-01 | 石家庄中天生物技术有限责任公司 | Method of producing D-p-hydroxy-phenyl glycine by heterogeneous enzyme catalysis method |
| CN106676157A (en) * | 2017-02-20 | 2017-05-17 | 南华大学 | Application of legionella thalli in preparing amino acid profile transformation agent |
| CN110714035A (en) * | 2019-11-15 | 2020-01-21 | 江南大学 | A kind of method for preparing D-aliphatic amino acid by cascade reaction |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1209495B (en) * | 1984-02-02 | 1989-08-30 | A San Donato Milanese Milano | PROCEDURE FOR THE PREPARATION OF L-ALPHA-AMINO ACIDS. |
| DE4316928C2 (en) * | 1993-05-19 | 1995-03-16 | Degussa | New microorganisms, their use and process for the production of L-alpha-amino acids |
| DE19519717C1 (en) * | 1995-05-30 | 1996-08-22 | Degussa | New microorganism DSM 9771 for prepn of L-alpha-amino acids |
| IT1276163B1 (en) * | 1995-11-23 | 1997-10-27 | Eniricerche Spa | IMPROVED PROCEDURE FOR THE PREPARATION OF D-ALPHA-AMINO ACIDS |
| NL1017250C1 (en) * | 2001-01-31 | 2002-08-01 | Dsm Nv | Process for the preparation of enantiomerically enriched amino acids. |
-
2001
- 2001-11-23 NL NL1019416A patent/NL1019416C2/en not_active IP Right Cessation
-
2002
- 2002-11-22 AU AU2002347652A patent/AU2002347652A1/en not_active Abandoned
- 2002-11-22 WO PCT/NL2002/000758 patent/WO2003044206A2/en not_active Ceased
- 2002-11-22 EP EP02783830A patent/EP1446492A2/en not_active Withdrawn
- 2002-11-22 CN CN 02823310 patent/CN1592789A/en active Pending
- 2002-11-22 JP JP2003545827A patent/JP2005509439A/en active Pending
Non-Patent Citations (1)
| Title |
|---|
| See references of WO03044206A3 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN1592789A (en) | 2005-03-09 |
| WO2003044206A3 (en) | 2003-12-18 |
| WO2003044206A2 (en) | 2003-05-30 |
| NL1019416C2 (en) | 2003-06-02 |
| AU2002347652A1 (en) | 2003-06-10 |
| AU2002347652A8 (en) | 2003-06-10 |
| JP2005509439A (en) | 2005-04-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US8460902B1 (en) | DNA encoding hydantoinase, DNA encoding N-carbamyl-L-amino acid hydrolase, recombinant DNA, transformed cell, method of producing protein, and method of producing optically active amino acid | |
| US20220220457A1 (en) | Nucleic acids encoding improved transaminase proteins | |
| EP1513946B1 (en) | Polypeptides having alpha-h-alpha amino acid amide racemase activity and nucleic acids encoding the same | |
| EP0330695B1 (en) | Process for preparation of organic chemicals | |
| JPH0851992A (en) | Method for producing D-α-amino acid | |
| EP1446492A2 (en) | Process for the preparation of an enantiomerically enriched a-amino acid | |
| Martínez-Rodríguez et al. | Molecular cloning and biochemical characterization of L-N-carbamoylase from Sinorhizobium meliloti CECT4114 | |
| JP2005509439A6 (en) | Process for producing enantiomerically rich α-amino acids | |
| JP4118687B2 (en) | D-carbamoylase derived from Arthrobacter crystallopoietes DSM20117 strain | |
| HUP0201850A2 (en) | Method for the production of l-amino acids from their racemic n-acetyl-d,l-derivatives by enzymatic racemate cleavage by means of isolated recombinant enzymes | |
| US7282356B2 (en) | D-aminoacylase mutants | |
| US7195900B2 (en) | Cloning and expression of D-amino acid oxidase from arthrobacter protophormiae | |
| US6352848B1 (en) | Recombinant L-N-carbamoylase from Arthrobacter aurescens and method of producing L-amino acids therewith | |
| US7776570B2 (en) | L-amino acid amide asymmetric hydrolase and DNA encoding the same | |
| EP1506294B1 (en) | Hydantoin racemase | |
| JP4402446B2 (en) | Mutant of D-aminoacylase | |
| US20060210989A1 (en) | Screening process for hydantoin racemases | |
| JP4231709B2 (en) | Novel dehydrogenase and gene encoding the same | |
| US20080003640A1 (en) | Deinococcus N-acylamino acid racemase and use of preparing L-amino acid | |
| WO2004005517A2 (en) | L-amidase from rhizobium huautlense | |
| JP2011024572A (en) | Method for producing optically active amino acid |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUAI | Public reference made under article 153(3) epc to a published international application that has entered the european phase |
Free format text: ORIGINAL CODE: 0009012 |
|
| 17P | Request for examination filed |
Effective date: 20040513 |
|
| AK | Designated contracting states |
Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR IE IT LI LU MC NL PT SE SK TR |
|
| AX | Request for extension of the european patent |
Extension state: AL LT LV MK RO SI |
|
| 17Q | First examination report despatched |
Effective date: 20041102 |
|
| GRAP | Despatch of communication of intention to grant a patent |
Free format text: ORIGINAL CODE: EPIDOSNIGR1 |
|
| STAA | Information on the status of an ep patent application or granted ep patent |
Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN |
|
| 18D | Application deemed to be withdrawn |
Effective date: 20081209 |